Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD)
PROGRAM DESCRIPTION This webcast is intended to improve care of patients with systemic sclerosis–associated interstitial lung disease (SSc-ILD) by accelerating adoption of new recommendations and evidence-based practice change. In-depth discussion ...
PROGRAM DESCRIPTION
This webcast is intended to improve care of patients with systemic sclerosis–associated interstitial lung disease (SSc-ILD) by accelerating adoption of new recommendations and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.
EDUCATIONAL OBJECTIVES
As a result of participating in the activity, learners should be better able to: Outline a multidisciplinary approach for the differential diagnosis of SSc-ILD and optimal management of common comorbiditiesEvaluate the latest evidence-based guidelines for idiopathic pulmonary fibrosis (IPF) and review strategies for individualized SSc-ILD management
Read more about this
Write the first review
Join now
to leave a review or read peer reviews!
Resource tags
Show all tags